- Investing Ideas
- /
- Global High Insider Buying
Global High Insider Buying
Results
2513
0 new
Stocks with high levels of insider buying the past 3 months and good analyst coverage.
2,513 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
UNH | US$480.22 | 2.8% | -1.8% | US$451.4b | US$629.96 | PE30.5x | E18.7% | 1.7% | Healthcare | ||
ORCL | US$148.79 | -8.2% | 30.4% | US$434.0b | US$194.19 | PE35.8x | E15.6% | 1.1% | Software | ||
JNJ | US$167.70 | 0.3% | 4.0% | US$401.3b | US$169.07 | PE28.7x | E7.9% | 3.0% | Pharmaceuticals & Biotech | ||
BX | US$139.37 | -12.1% | 11.9% | US$177.3b | US$182.38 | PE38.6x | E24.6% | 2.8% | Diversified Financials | ||
AMD | US$96.63 | -1.6% | -51.3% | US$162.6b | US$148.34 | PE95.4x | E32.0% | n/a | Semiconductors | ||
PFE | US$26.64 | 1.5% | -6.1% | US$151.5b | US$30.89 | PE18.8x | E3.9% | 6.5% | Pharmaceuticals & Biotech | ||
LOW | US$242.38 | -1.5% | 0.6% | US$135.9b | US$279.81 | PE19.6x | E6.1% | 1.9% | Retail | ||
BHP | AU$39.65 | 0.4% | -6.7% | AU$198.8b | AU$44.99 | PE11.1x | E-0.7% | 4.0% | Materials | ||
BMY | US$63.11 | 5.4% | 16.1% | US$124.0b | US$61.24 | PS2.7x | E32.6% | 3.9% | Pharmaceuticals & Biotech | ||
COP | US$92.90 | 0.3% | -19.4% | US$115.3b | US$129.52 | PE12.8x | E4.4% | 3.4% | Energy | ||
RIO | UK£48.29 | -1.0% | 0.4% | UK£82.1b | UK£57.59 | PE8.7x | E-0.1% | 6.5% | Materials | ||
INVE A | SEK 307.50 | -5.0% | 18.2% | SEK 943.2b | SEK 315.00 | PE8.3x | E-48.3% | 1.7% | Diversified Financials | ||
ENB | CA$61.63 | -0.4% | 26.9% | CA$134.3b | CA$64.43 | PE26.6x | E10.4% | 6.1% | Energy | ||
1299 | HK$62.80 | 6.4% | 0.9% | HK$669.2b | HK$92.23 | PE17.8x | E13.8% | 2.6% | Insurance | ||
BP. | UK£4.18 | -3.3% | -11.3% | UK£66.6b | UK£4.92 | PE219.8x | E24.0% | 5.9% | Energy | ||
CVS | US$65.23 | 0.5% | -14.1% | US$83.6b | US$72.46 | PE17.8x | E14.4% | 4.1% | Healthcare | ||
ATCO A | SEK 179.15 | -1.2% | 0.03% | SEK 836.7b | SEK 187.30 | PE29.3x | E6.7% | 1.7% | Capital Goods | ||
GSK | UK£15.59 | 5.3% | -7.0% | UK£63.5b | UK£18.12 | PE24.7x | E18.1% | 3.9% | Pharmaceuticals & Biotech | ||
IBKR | US$167.16 | -17.1% | 55.2% | US$81.2b | US$228.00 | PE24.1x | E2.6% | 0.6% | Diversified Financials | ||
RR. | UK£7.33 | -5.7% | 91.2% | UK£61.5b | UK£7.78 | PE24.4x | E2.5% | 0.8% | Capital Goods | ||
PNC | US$174.61 | -7.9% | 14.2% | US$71.1b | US$217.93 | PB1.4x | E10.0% | 3.7% | Banks | ||
BBCA | Rp8,925.00 | 1.4% | -12.1% | Rp1100.2t | Rp11,598.36 | PB4.2x | E7.7% | 3.1% | Banks | ||
WBC | AU$30.69 | -3.7% | 13.6% | AU$104.1b | AU$28.58 | PB1.5x | E1.1% | 5.0% | Banks | ||
SPG | US$165.29 | -12.0% | 10.3% | US$64.5b | US$190.89 | PB18.6x | E1.0% | 5.1% | Real Estate |